Page 9 | Certara

Blog

Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting

Stay compliant with EU rules for the pharmaceutical industry. Learn about annual safety reports and…

CertaraSeptember 5, 2025

Blog

Best Practices for Safety Narrative Writing in Clinical Research

Explore the patient narrative format in medical writing and why narrative writing in clinical research…

CertaraSeptember 5, 2025

Conference

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

CertaraSeptember 4, 2025

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

CertaraSeptember 4, 2025

Press Release

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Pinnacle 21® Enterprise Plus delivers a 50% reduction in time spent drafting mapping specifications, according…

CertaraSeptember 4, 2025

On-Demand Webinar

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Watch leading experts from Pfizer, Merck, Amicus, and Certara discuss how Integrated Evidence can bridge…

CertaraSeptember 3, 2025

Press Release

Certara to Participate in Upcoming Investor Conferences

RADNOR, PA – September 2, 2025 -- Certara, Inc. (Nasdaq: CERT), a global leader in…

Danielle PillsburySeptember 2, 2025

On-Demand Webinar

Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH)

Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…

CertaraAugust 29, 2025

Live Events

Phoenix Roadshow 2025 – Basel

CertaraAugust 29, 2025

On-Demand Webinar

Streamline Table Creation with AI-Specialized for Regulatory Writers

Learn how AI-powered CoAuthor™ transforms table creation for regulatory and medical writers. Watch our free…

CertaraAugust 27, 2025

Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting

Best Practices for Safety Narrative Writing in Clinical Research

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Certara to Participate in Upcoming Investor Conferences

Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH)

Phoenix Roadshow 2025 – Basel

Streamline Table Creation with AI-Specialized for Regulatory Writers

Newsletter sign up

Quick links

Solutions

Contact